If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Quality, Compliance and Regulatory » Regulatory Affairs
Download FREE Excerpt
13 Info Graphics
16 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
With regulators focused on the safety of new products, pharmaceutical organizations face ever increasing regulatory requirements for their new products. To meet these new standards, pharmaceutical organizations are relying on internal and external resources to support their risk-mitigation programs and meet compliance goals.
This new research study from Best Practices, LLC, examines the internal and external resources that leading organizations use to support Risk Evaluation & Mitigation Strategy (REMS) programs. In addition, the study reviews the challenges of implementing communication plans and trends in the European market for implementing Risk Minimization Plans (RMPs).
Best Practices, LLC conducted this research to help REMS leaders understand current trends in dealing with risk mitigation plans.